Company intelligence / Profile preview

Stargate

Ownership: Private
Development stage: Other

Overview

The Stargate initiative is a $500 billion private-sector partnership between Oracle, OpenAI, SoftBank, MGX and other technology leaders. Its primary goal is to build state-of-the-art data centers across the U.S. to power advanced artificial intelligence applications in healthcare—especially for early cancer detection and rapid development of personalized mRNA-based cancer vaccines. The project aims to enable creation of individualized cancer vaccines within as little as two days by leveraging massive computational resources for genomics analysis and drug design.

Therapeutic areas: Oncology
Modalities: mRNA-based drugs (cancer vaccines)Artificial intelligence-driven drug discovery platforms
Industry: Drug Discovery Services

Partnerships

OracleOpenAISoftBankMGXArmMicrosoftNVIDIA

Beyond the preview

Go deeper on Stargate.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stargate.

Explore the full profile